Tirzepatide 10 mg
  1. Home
  2. Mounjaro
  3. Tirzepatide 10 mg

Tirzepatide 10 mg

Tirzepatide 10 mg is a prescription dual GIP and GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is administered as a once-weekly subcutaneous injection using a prefilled injection pen. The 10 mg strength is commonly prescribed as part of the maintenance treatment regimen following gradual dose escalation.

BUY NOW

Category

Tirzepatide 10 mg contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The 10 mg dose is typically prescribed after progressive dose escalation to provide sustained glycemic control and support long-term metabolic management when clinically appropriate. Manufactured under stringent pharmaceutical quality standards, the sterile prefilled injection pen is engineered for precise subcutaneous administration and dependable clinical performance. Tirzepatide 10 mg should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Tirzepatide 10 mg
Active Ingredient Tirzepatide
Strength 10 mg
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Tirzepatide 10 mg, Tirzepatide Injection 10 mg, Tirzepatide Prefilled Pen, Weekly Tirzepatide Injection, GIP GLP-1 Receptor Agonist, Diabetes Injection Pen, Tirzepatide Injectable Pen